Pirfenidone Tablet, Film Coated
Product Images NDC 72205-182

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 72205-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pirfenidone-267mg-270s-carton-label (Pirfenidone 267mg 270s Carton Label)

This appears to be a product label for Pirfenidone Tablets made by Novadoz. The label includes information such as the name of the medication, the manufacturer, the dosage and quantity of tablets, and a lot number and expiration date. The illegible text makes it difficult to discern any additional details.*

FDA Label Image

Pirfenidone-267mg-30s-cntr-label (Pirfenidone 267mg 30s Cntr Label)

This is a medication package for Pirfenidone tablets distributed by Novadoz Pharmaceuticals LLC. The package contains 30 tablets and the usual dosage information can be found in the package insert. The tablets should be stored at 25°C (77°F) with excursions permitted. The manufacturer is MSN Laboratories Private Limited in Telangana, India. The package also includes the relevant product codes and issue dates.*

FDA Label Image

Pirfenidone-267mg-90s-carton-label (Pirfenidone 267mg 90s Carton Label)

This is a product description for Novadoz Pirfenidone Tablets in a package containing 90 tablets divided into 3 bottles of 30 tablets each. The NDC code is 72205-181-36 and the batch number is 220518138. The drug is used for the treatment of idiopathic pulmonary fibrosis.*

FDA Label Image

Pirfenidone-801mg-30s-cntr-label (Pirfenidone 801mg 30s Cntr Label)

This is a medication called Pirfenidone contained in film-coated tablets. Each tablet contains 801mg of the medication. The usual dosage instructions can be found in the package insert. The medication should be kept at a temperature between 15-30°C and must be kept out of children's reach. It is manufactured by WISN Laboratories Private Limited in Telangana, India and distributed by B A in Pscataway, X in a package of 30 tablets. The M.L.No. is 5/MN/TS/2014/F/G.*

FDA Label Image

Pirfenidone-801mg-90s-carton-label (Pirfenidone 801mg 90s Carton Label)

FDA Label Image

Fig1 (Pirfenidone Figure 1)

FDA Label Image

Fig2 (Pirfenidone Figure 2)

FDA Label Image

Fig3 (Pirfenidone Figure 3)

This appears to be a survival analysis study that compares the impact of Pirfenidone vs placebo on patients' survival. There were 623 patients in the Pirfenidone group and 624 in the placebo group. The percentage of patients alive was measured over time, and a Hazard Ratio (HR) was calculated with a 95% Confidence Interval (CI) of 0.75 (0.51 - 1.11). The study followed patients for up to 120 weeks, and the number of patients at risk decreased over time for both groups.*

FDA Label Image

Str (Pirfenidone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.